Bringing innovative therapies to patients

Scroll down

Draupnir Bio is developing new innovative therapies for patients.

Latest news

News

Draupnir Bio establishes Scientific Advisory Board of international experts in cholesterol metabolism and cardiovascular disease

September 2021

4 min

Draupnir Bio expands research operations with new facility at INCUBA research park

News

Draupnir Bio expands research operations with new facility at INCUBA research park

August 2021

2 minutes read

Anna Quattropani joins Draupnir Bio as CDO

News

Draupnir Bio strengthens senior management with the appointment of Anna Quattropani as Chief Discovery Officer

July 2021

3 min

Andrew Hotchkiss joins Draupnir Bio as CEO

News

Andrew Hotchkiss joins Draupnir Bio as Chief Executive Officer

June 2021

3 min

News

Draupnir Bio secures Euro 30 million in Series A funding round

October 2019

2 min

Join us

We’re always looking for talented individuals who share our dedication to drug discovery and innovation.

Check back here regularly for open positions.